MIRAGE syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:494433OMIM:617053D46.7
Who is this for?
Show terms as
1FDA treatments9Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

MIRAGE syndrome is a very rare genetic condition caused by changes in the SAMD9 gene. The name MIRAGE is an acronym that stands for the main features of the condition: Myelodysplasia (problems with blood cell production), Infection susceptibility (getting sick easily), Restriction of growth (very small size before and after birth), Adrenal hypoplasia (small or underdeveloped adrenal glands), Genital phenotypes (differences in genital development), and Enteropathy (digestive problems). Because the adrenal glands do not work properly, the body cannot make enough of certain hormones that are essential for life, especially during times of stress or illness. This makes adrenal crisis — a sudden, life-threatening drop in these hormones — one of the most serious risks for people with MIRAGE syndrome. Children with MIRAGE syndrome are typically very small at birth and continue to grow slowly. They often have a weakened immune system, making them prone to serious infections. Blood cell problems can range from low counts of certain blood cells to a condition called myelodysplastic syndrome, which affects how the bone marrow makes blood cells. Digestive issues such as poor feeding, diarrhea, and difficulty absorbing nutrients are also common. Some children may have differences in the development of their sex organs. There is currently no cure for MIRAGE syndrome. Treatment focuses on managing each symptom as it appears. Hormone replacement therapy for adrenal insufficiency is critical and can be life-saving. Infections are treated promptly, and nutritional support is often needed. Because this condition affects so many body systems, a team of specialists is usually involved in care. The long-term outlook varies widely, and some children have severe complications early in life.

Also known as:

Key symptoms:

Very small size at birth (severe intrauterine growth restriction)Slow growth after birthAdrenal glands that are too small or do not work properly (adrenal hypoplasia)Low levels of stress hormones, which can cause life-threatening adrenal crisisWeakened immune system leading to frequent or severe infectionsProblems with blood cell production (myelodysplasia)Low red blood cell counts (anemia)Low platelet counts, causing easy bruising or bleedingDigestive problems such as diarrhea, poor feeding, or difficulty absorbing nutrientsDifferences in genital or reproductive organ developmentChromosome 7 abnormalities in blood cells (monosomy 7)Failure to thriveSkin changes or unusual skin findings in some casesDevelopmental delays in some children

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

3 events
Jul 2022Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

IRCCS Azienda Ospedaliero-Universitaria di Bologna — NA

TrialRECRUITING
May 2020CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study

Jonsson Comprehensive Cancer Center

TrialACTIVE NOT RECRUITING
Apr 2017

Alunbrig: FDA approved

Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib

FDAcompleted

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Alunbrig

brigatinib· Takeda Development Center Americas, Inc.Orphan Drug

Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib

No actively recruiting trials found for MIRAGE syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the MIRAGE syndrome community →

Specialists

9 foundView all specialists →
GM
Giuseppe Lombardi, MD
Specialist
PI on 1 active trial1 MIRAGE syndrome publication
BP
Bret Goodpaster, PhD
Specialist
PI on 3 active trials
PN
Patrick VQ Nguyen
Specialist
PI on 1 active trial49 MIRAGE syndrome publications
AK
Amar Kishan
LOS ANGELES, CA
Specialist
PI on 1 active trial
RM
Ricci Claudio, MD
Specialist
PI on 1 active trial
TP
Theodore Wagener, PhD
OKLAHOMA CITY, OK
Specialist
PI on 1 active trial
SP
Sandra Ten Bruggencate, PhD
Specialist
PI on 1 active trial
LP
Lindsay Farrer, PhD
BOSTON, MA
Specialist
PI on 1 active trial
SN
Satoshi Narumi
Specialist
2 MIRAGE syndrome publications

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Alunbrig(brigatinib)Takeda Development Center Americas, Inc.

Travel Grants

No travel grants are currently matched to MIRAGE syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open MIRAGE syndromeForum →

No community posts yet. Be the first to share your experience with MIRAGE syndrome.

Start the conversation →

Latest news about MIRAGE syndrome

Disease timeline:

New recruiting trial: Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

A new clinical trial is recruiting patients for MIRAGE syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What signs of adrenal crisis should I watch for, and exactly what should I do if one happens?,How often does my child need blood tests to monitor their blood cell counts and hormone levels?,Should my child carry a medical alert card or wear a medical ID bracelet?,What infections are most dangerous for my child, and are there any preventive treatments like immunoglobulin therapy?,Is bone marrow transplant something we should consider, and when would that decision be made?,Are there any clinical trials or research studies my child might be eligible for?,What specialists should be part of my child's care team, and how often should we see each one?

Common questions about MIRAGE syndrome

What is MIRAGE syndrome?

MIRAGE syndrome is a very rare genetic condition caused by changes in the SAMD9 gene. The name MIRAGE is an acronym that stands for the main features of the condition: Myelodysplasia (problems with blood cell production), Infection susceptibility (getting sick easily), Restriction of growth (very small size before and after birth), Adrenal hypoplasia (small or underdeveloped adrenal glands), Genital phenotypes (differences in genital development), and Enteropathy (digestive problems). Because the adrenal glands do not work properly, the body cannot make enough of certain hormones that are esse

How is MIRAGE syndrome inherited?

MIRAGE syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does MIRAGE syndrome typically begin?

Typical onset of MIRAGE syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat MIRAGE syndrome?

9 specialists and care centers treating MIRAGE syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.